BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16250308)

  • 1. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
    Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
    Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
    Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
    Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
    Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
    Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy.
    Salehzadeh M; Aghamohammadi A; Rezaei N
    J Microbiol Immunol Infect; 2010 Feb; 43(1):11-7. PubMed ID: 20434118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R; Visitsunthorn N; Vichyanond P
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
    Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
    J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoglobulin therapy of primary humoral immunologic deficiencies].
    Bordigoni P
    Rev Prat; 2007 Oct; 57(15):1691-8. PubMed ID: 18080428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
    Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
    An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.
    Pourpak Z; Aghamohammadi A; Sedighipour L; Farhoudi A; Movahedi M; Gharagozlou M; Chavoshzadeh Z; Jadid L; Rezaei N; Moin M
    J Microbiol Immunol Infect; 2006 Apr; 39(2):114-20. PubMed ID: 16604243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
    Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin treatment in primary antibody deficiency.
    Maarschalk-Ellerbroek LJ; Hoepelman IM; Ellerbroek PM
    Int J Antimicrob Agents; 2011 May; 37(5):396-404. PubMed ID: 21276714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
    Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
    Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.
    Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
    Atarod L; Aghamohammadi A; Moin M; Kanegane H; Rezaei N; Rezaei Kalantari K; Amirzagar AA; Futatani T; Miyawaki M
    Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):37-40. PubMed ID: 17303928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
    Favre O; Leimgruber A; Nicole A; Spertini F
    Allergy; 2005 Mar; 60(3):385-90. PubMed ID: 15679727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.
    Aghamohammadi A; Moin M; Farhoudi A; Rezaei N; Pourpak Z; Movahedi M; Gharagozlou M; Nabavi M; Shahrokhi A
    FEMS Immunol Med Microbiol; 2004 Mar; 40(2):113-8. PubMed ID: 14987729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
    Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
    J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
    Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
    Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.